Page last updated: 2024-10-25

ciclopirox and Erythema

ciclopirox has been researched along with Erythema in 4 studies

Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.

Research Excerpts

ExcerptRelevanceReference
" There are limited data on adverse events associated with the newer topical onychomycosis drugs."1.56Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration. ( Lipner, SR; Wang, Y, 2020)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Wang, Y1
Lipner, SR1
Turchin, I1
Adams, SP1
Enta, T1
Rosen, T1
Schell, BJ1
Orengo, I1

Trials

1 trial available for ciclopirox and Erythema

ArticleYear
Anti-inflammatory activity of antifungal preparations.
    International journal of dermatology, 1997, Volume: 36, Issue:10

    Topics: Adult; Allylamine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Age

1997

Other Studies

3 other studies available for ciclopirox and Erythema

ArticleYear
Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
    Archives of dermatological research, 2020, Volume: 312, Issue:8

    Topics: Administration, Topical; Adverse Drug Reaction Reporting Systems; Antifungal Agents; Boron Compounds

2020
Dermacase. Pityriasis rosea.
    Canadian family physician Medecin de famille canadien, 2004, Volume: 50

    Topics: Acute Disease; Adolescent; Antifungal Agents; Ciclopirox; Diagnosis, Differential; Erythema; Humans;

2004
Ciclopirox (Penlac) nail lacquer for onychomycosis.
    The Medical letter on drugs and therapeutics, 2000, Jun-12, Volume: 42, Issue:1080

    Topics: Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Dose-Response Relationship, Drug; Erythema;

2000